The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferris, R. L.
Right arrow Articles by Siliciano, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferris, R. L.
Right arrow Articles by Siliciano, R. F.

The Journal of Immunology, Vol 156, Issue 2 834-840, Copyright © 1996 by American Association of Immunologists


ARTICLES

Class I-restricted presentation of an HIV-1 gp41 epitope containing an N-linked glycosylation site. Implications for the mechanism of processing of viral envelope proteins

RL Ferris, C Buck, SA Hammond, AS Woods, RJ Cotter, M Takiguchi, Y Igarashi, Y Ichikawa and RF Siliciano
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Uncertainty exists over the site of processing of viral envelope (env) proteins for recognition by CTL. The extracellular domains of env proteins are not present in the cytosol, the site where the class I Ag processing pathway begins. Rather, the ecto-domains of env proteins are cotranslationally translocated into the endoplasmic reticulum during biosynthesis. To clarify the site of processing of viral env proteins, we examined the processing of an HLA B*3501-restricted epitope in the extracellular domain of the HIV-1 env protein. Although this epitope contains an N-linked glycosylation signal sequence, CTL specific for this epitope recognize a nonameric peptide that has not been previously modified by attachment of oligosaccharide. This was demonstrated in two ways. First, an env-specific B*3501-restricted CTL clone recognized a nonglycosylated, synthetic nonamer representing the minimal B*3501- restricted epitope, but not the glycosylated or deglycosylated forms. Second, the naturally processed, B*3501-restricted, env peptide is identical with a nonglycosylated, synthetic nonamer. Thus, the naturally processed form of an env epitope containing an N-linked glycosylation site is derived from env protein that is not glycosylated at the relevant asparagine during biosynthesis. Since the addition of N- linked oligosaccharides occurs only after the glycosylation signal sequence (N-X-S/T) is translocated into the endoplasmic reticulum, the initial processing reaction for this epitope may take place in the cytosol. Low-frequency failure of signal sequence containing polypeptides to engage the translocation apparatus, resulting in synthesis and degradation in the cytosol, may represent an important mechanism for the generation of class I-restricted CTL responses.


This article has been cited by other articles:


Home page
J. Immunol.Home page
S. B. J. Wong, C. B. Buck, X. Shen, and R. F. Siliciano
An Evaluation of Enforced Rapid Proteasomal Degradation as a Means of Enhancing Vaccine-Induced CTL Responses
J. Immunol., September 1, 2004; 173(5): 3073 - 3083.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. N. Golovina, E. J. Wherry, T. N. J. Bullock, and L. C. Eisenlohr
Efficient and Qualitatively Distinct MHC Class I-Restricted Presentation of Antigen Targeted to the Endoplasmic Reticulum
J. Immunol., March 15, 2002; 168(6): 2667 - 2675.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
C. A. Herberts, K. J. Stittelaar, E. van der Heeft, J. van Gaans-van den Brink, M. C. M. Poelen, P. J. M. Roholl, L. J. W. van Alphen, C. J. M. Melief, A. P. J. M. de Jong, and C. A. C. M. van Els
A measles virus glycoprotein-derived human CTL epitope is abundantly presented via the proteasomal-dependent MHC class I processing pathway
J. Gen. Virol., September 1, 2001; 82(9): 2131 - 2142.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Hudrisier, J. Riond, H. Mazarguil, M. B. A. Oldstone, and J. E. Gairin
Genetically Encoded and Post-translationally Modified Forms of a Major Histocompatibility Complex Class I-restricted Antigen Bearing a Glycosylation Motif Are Independently Processed and Co-presented to Cytotoxic T Lymphocytes
J. Biol. Chem., December 17, 1999; 274(51): 36274 - 36280.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. L. Ferris, C. Hall, N. V. Sipsas, J. T. Safrit, A. Trocha, R. A. Koup, R. P. Johnson, and R. F. Siliciano
Processing of HIV-1 Envelope Glycoprotein for Class I-Restricted Recognition: Dependence on TAP1/2 and Mechanisms for Cytosolic Localization
J. Immunol., February 1, 1999; 162(3): 1324 - 1332.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Selby, A. Erickson, C. Dong, S. Cooper, P. Parham, M. Houghton, and C. M. Walker
Hepatitis C Virus Envelope Glycoprotein E1 Originates in the Endoplasmic Reticulum and Requires Cytoplasmic Processing for Presentation by Class I MHC Molecules
J. Immunol., January 15, 1999; 162(2): 669 - 676.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
C. A. Mosse, L. Meadows, C. J. Luckey, D. J. Kittlesen, E. L. Huczko, C. L. Slingluff Jr., J. Shabanowitz, D. F. Hunt, and V. H. Engelhard
The Class I Antigen-processing Pathway for the Membrane Protein Tyrosinase Involves Translation in the Endoplasmic Reticulum and Processing in the Cytosol
J. Exp. Med., January 5, 1998; 187(1): 37 - 48.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Hudrisier, J. Riond, H. Mazarguil, and J. E. Gairin
Pleiotropic Effects of Post-translational Modifications on the Fate of Viral Glycopeptides as Cytotoxic T Cell Epitopes
J. Biol. Chem., October 5, 2001; 276(41): 38255 - 38260.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.